James Levine
Fortune : 128 660 $ au 31/05/2026
Fortune : 128 660 $ au 31/05/2026
James E.
Levine is currently Chief Financial Officer at Kazia Therapeutics Ltd. since 2026.
Formerly, Chief Financial Officer at Cardiff Oncology, Inc. from 2021 to 2026.
Chief Financial Officer at Cidara Therapeutics, Inc. from 2018 to 2021.
President, Chief Executive & Financial Officer at Sapphire Energy, Inc. from 2014 to 2018.
President & Chief Executive Officer at Verenium Corp.
from 2013 to 2014.
Director at Biotechnology Innovation Organization from 1997 to 2000.
Chief Executive Officer & Director at Annai Systems, Inc. Managing Director-Investment Banking at Goldman Sachs & Co. LLC.
Education includes undergraduate degree from Brandeis University and MBA from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 67 716 ( 0,1% ) | 128 660 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur Financier/CFO | 01/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Directeur Financier/CFO | 27/01/2026 |
| CIDARA THERAPEUTICS | Directeur Financier/CFO | 09/07/2021 |
Sapphire Energy, Inc.
Sapphire Energy, Inc. Oil & Gas ProductionEnergy Minerals Develops and produces algae-based crude oil | Directeur Général | 30/11/2018 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2000 |
Annai Systems, Inc.
Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Kazia Therapeutics Ltd.
Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Sapphire Energy, Inc.
Sapphire Energy, Inc. Oil & Gas ProductionEnergy Minerals Develops and produces algae-based crude oil | Energy Minerals |
Annai Systems, Inc.
Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Technology Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verenium Corp.
Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national